Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma

doi:10.12998/wjcc.v13.i25.105204

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 25

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (680)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

419

Figures (1-2)

Tables (1-4)

Sum=563

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=98

Sep 6, 2025 (publication date) through Jul 28, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Cases. Sep 6, 2025; 13(25): 105204
Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.105204

Open in New Tab Full Size Figure Download Figure

Figure 1 Flowchart of cohort establishment.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan–Meier curves of cancer-specific survival in poorly differentiated thyroid carcinoma patients. A: Kaplan–Meier survival curves for patients with (N1) and without (N0) lymph node metastasis; B: Kaplan–Meier survival curves for patients with distant metastasis at presentation (M1), distant metastasis developing during follow-up (M2), and no metastasis (M0); C: Kaplan–Meier survival curves for poorly differentiated thyroid carcinoma patients with stages I, II, III, and IV disease at diagnosis.

Citation: Hsu CW, Hsueh C, Lu YL, Hsu CJ, Wong RJ, Lin SF. Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma. World J Clin Cases 2025; 13(25): 105204
URL: https://www.wjgnet.com/2307-8960/full/v13/i25/105204.htm
DOI: https://dx.doi.org/10.12998/wjcc.v13.i25.105204